ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,467Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 315

$742K Total Retail Price of All Prescriptions

Rank: 28 out of 315

468 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 468 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

10% of this provider’s 468 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 8,820 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LISINOPRIL 755 634 1 3
SIMVASTATIN 608 474 2 1
LOVASTATIN 514 419 3 8
FELODIPINE ER 490 459 10 4 23
AMLODIPINE BESYLATE 409 317 5 2
LOSARTAN POTASSIUM 329 281 6 4
METFORMIN HCL 320 281 7 7
LEVOTHYROXINE SODIUM 274 215 8 6
METOPROLOL SUCCINATE 271 230 9 13
ATORVASTATIN CALCIUM 251 219 10 5
HYDROCHLOROTHIAZIDE 246 207 11 16
HYDROCODONE-ACETAMINOPHEN 218 109 S3 12 19
METOPROLOL TARTRATE 197 130 13 18
ALENDRONATE SODIUM 180 178 14 12
OMEPRAZOLE 180 129 14 9
FUROSEMIDE 179 113 16 15
ATENOLOL 173 125 17 11
ALLOPURINOL 165 135 18 14
WARFARIN SODIUM 155 130 19 20
GLYBURIDE-METFORMIN HCL 141 101 R 20 87
PRAVASTATIN SODIUM 135 92 21 10
ZOLPIDEM TARTRATE 121 98 22 29
CLOPIDOGREL 117 106 23 25
POTASSIUM CHLORIDE 116 80 24 36
ACTOS 116 98 24 78
EVISTA 113 113 26 48
CARVEDILOL 101 69 27 22
GLIPIZIDE 93 72 28 30
GABAPENTIN 89 13 29 37
OXYCODONE HCL 88 43 S2 30 57
ISOSORBIDE MONONITRATE ER 85 55 31 92
TAMSULOSIN HCL 84 79 32 21
DIOVAN 82 60 33 27
DIGOXIN 76 36 34 45
PANTOPRAZOLE SODIUM 75 75 35 35
PLAVIX 72 69 36 40
BYETTA 65 48 37 297
SERTRALINE HCL 64 41 38 100
CYMBALTA 62 24 39 165
PEN NEEDLE 61 47 40 91
IRBESARTAN 61 57 40 66
SINGULAIR 58 35 42 153
TRIAMTERENE-HCTZ 57 55 43 71
HUMALOG MIX 75-25 54 37 44 205
FAMOTIDINE 54 25 44 75
ZOLPIDEM TARTRATE ER 53 53 46 321
GLIPIZIDE ER 52 45 47 55
OXYCONTIN 52 14 S2 47 192
FINASTERIDE 51 51 49 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.